Suppliers / Becton Dickinson and

Becton Dickinson and

United States BDX Updated 9 July 2026

Becton Dickinson and is a finished-dose manufacturer based in United States. It appears in 145 regulatory filings across 12 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE), AIFA (IT) and US FDA. Its GMP standing is certified by NAFDAC (NG), ANSM (FR) and HSA (SG), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 14 December 2018 as VAI. Customs aggregates show $10K of exports covering 6 molecules to 1 destination in 2025.

0
active US DMFs
0
valid CEPs
8
registered plants 1 with an FDA FEI number
145
filings across 12 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
3 of 3 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 14 December 2018 VAI US FDA
  • 6 December 2013 NAI US FDA
  • 26 March 2009 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Columbus, United Arab Emirates Not on file
Co Louth, United Arab Emirates Not on file
Singapore, United Arab Emirates Not on file
Fraga (Huesca), United Arab Emirates Not on file
Canaan, United Arab Emirates Not on file
Le Pont-De-Claix, France Not on file

2 further sites are on record.

Filings and GMP by regulator

Regulator Filings GMP certificates
EDE (AE) 57 None
AIFA (IT) 19 None
US FDA 16 None
EMA 12 1
NAFDAC (NG) 12 6
FAMHP (BE) 10 None
ANSM (FR) None 5
HSA (SG) None 2

Scale

Year Revenue Exports Destinations
2025 $21.8B $10K 1
2024 $20.2B $13K 1
2023 $19.4B $15K 2
2022 Not reported $5K 1

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Becton Dickinson and comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 100 active litigation matters are on record.
  • The most recent inspection outcome was VAI, on 14 December 2018.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts
Company filings
Revenue as reported